5AM Venture Management, LLC - Q1 2021 holdings

$555 Million is the total value of 5AM Venture Management, LLC's 11 reported holdings in Q1 2021. The portfolio turnover from Q4 2020 to Q1 2021 was 10.0% .

 Value Shares↓ Weighting
VOR NewVOR BIOPHARMA INC$288,444,0006,692,429
+100.0%
51.94%
AKUS  AKOUOS INC$57,363,000
-30.1%
4,135,7840.0%10.33%
-62.6%
FIXX  HOMOLOGY MEDICINES INC$42,683,000
-16.7%
4,535,9190.0%7.69%
-55.4%
IDYA  IDEAYA BIOSCIENCES INC$42,255,000
+67.9%
1,798,0660.0%7.61%
-10.3%
CABA SellCABALETTA BIO INC$33,125,000
-21.3%
2,984,263
-11.5%
5.96%
-57.9%
ARVN  ARVINAS INC$33,050,000
-22.2%
500,0000.0%5.95%
-58.4%
SCPH  SCPHARMACEUTICALS INC$25,479,000
+25.7%
3,831,4740.0%4.59%
-32.8%
CRNX  CRINETICS PHARMACEUTICALS IN$20,816,000
+8.3%
1,362,2860.0%3.75%
-42.1%
CDTX  CIDARA THERAPEUTICS INC$5,337,000
+33.0%
2,006,5110.0%0.96%
-28.9%
FVAM  5 01 ACQUISITION CORP$3,648,000
-1.8%
365,1260.0%0.66%
-47.4%
APRE SellAPREA THERAPEUTICS INC$3,158,000
-53.4%
619,157
-55.1%
0.57%
-75.1%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2021-05-17
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
HOMOLOGY MEDICINES INC16Q3 202326.6%
ARVINAS INC16Q3 202314.3%
Crinetics Pharmaceuticals, Inc.16Q3 202312.8%
SCPHARMACEUTICALS INC16Q3 20237.5%
CIDARA THERAPEUTICS INC16Q3 20231.7%
IDEAYA BIOSCIENCES INC14Q1 202311.4%
VOR BIOPHARMA INC11Q3 202351.9%
CABALETTA BIO INC11Q2 202214.2%
AKOUOS INC10Q3 202227.7%
IMPEL PHARMACEUTICALS INC10Q3 20237.1%

View 5AM Venture Management, LLC's complete holdings history.

Latest filings
TypeFiled
13F-HR2024-02-14
13F-HR2023-11-14
13F-HR2023-08-14
13F-HR2023-05-15
13F-HR2023-02-14
13F-HR2022-11-14
13F-HR2022-08-15
13F-HR2022-05-16
13F-HR2022-02-03
13F-HR2021-11-15

View 5AM Venture Management, LLC's complete filings history.

Compare quarters

Export 5AM Venture Management, LLC's holdings